pharma stocks
Vericel reports Q2 earnings beat, raises outlook
Vericel Corporation (NASDAQ: VCEL) reported better-than-expected results in the second quarter aided by strong growth from both of its products.…
Solid Biosciences tumbles 38% to hit historic low
Shares of Solid Biosciences Inc. (NASDAQ: SLDB) opened 38% lower on Tuesday after the company said in its first-quarter results…
KEYTRUDA helps Merck to report Q1 earnings beat, raises 2019 outlook
Shares of the pharma giant Merck (MRK) rose 2% before the market hours after the company surpassed estimates on the…
Cancer drugs boost AstraZeneca results in Q1
Riding on the strong demand for its cancer drugs, AstraZeneca Plc (NYSE: AZN) on Friday reported its third consecutive quarter…